Free Trial

Boston Scientific (BSX) Competitors

Boston Scientific logo
$93.66 +1.02 (+1.10%)
Closing price 04/11/2025 03:59 PM Eastern
Extended Trading
$94.23 +0.57 (+0.61%)
As of 04/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, RMD, IDXX, DXCM, and STE

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Boston Scientific vs.

Boston Scientific (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability, institutional ownership and community ranking.

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$16.75B8.27$1.85B$1.2574.93
Abbott Laboratories$41.95B5.24$13.40B$7.6516.58

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.5% of Boston Scientific shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Boston Scientific received 111 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.97% of users gave Abbott Laboratories an outperform vote while only 69.72% of users gave Boston Scientific an outperform vote.

CompanyUnderperformOutperform
Boston ScientificOutperform Votes
1057
69.72%
Underperform Votes
459
30.28%
Abbott LaboratoriesOutperform Votes
946
69.97%
Underperform Votes
406
30.03%

Boston Scientific has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

In the previous week, Abbott Laboratories had 8 more articles in the media than Boston Scientific. MarketBeat recorded 45 mentions for Abbott Laboratories and 37 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.40 beat Abbott Laboratories' score of 1.40 indicating that Boston Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boston Scientific
30 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Abbott Laboratories
40 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Boston Scientific currently has a consensus target price of $109.04, suggesting a potential upside of 16.43%. Abbott Laboratories has a consensus target price of $137.94, suggesting a potential upside of 8.75%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific
0 Sell rating(s)
1 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
3.00
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.84

Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Boston Scientific11.07% 17.80% 9.85%
Abbott Laboratories 31.95%20.74%11.19%

Summary

Boston Scientific and Abbott Laboratories tied by winning 9 of the 18 factors compared between the two stocks.

Remove Ads
Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$138.54B$4.05B$5.25B$18.30B
Dividend YieldN/A44.86%5.34%4.13%
P/E Ratio74.9327.5821.3630.71
Price / Sales8.2745.68366.3225.88
Price / Cash28.8651.0838.1517.55
Price / Book6.285.736.284.25
Net Income$1.85B$67.09M$3.19B$1.02B
7 Day Performance4.33%0.24%0.66%1.34%
1 Month Performance-2.86%-8.50%-11.10%-7.29%
1 Year Performance37.59%8.15%4.51%-1.36%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSX
Boston Scientific
4.4313 of 5 stars
$93.66
+1.1%
$109.04
+16.4%
N/A$138.54B$16.75B74.9345,000Analyst Forecast
Positive News
Gap Down
ABT
Abbott Laboratories
4.8503 of 5 stars
$124.77
+0.3%
$137.94
+10.6%
N/A$216.42B$41.95B16.31115,000Upcoming Earnings
Positive News
ISRG
Intuitive Surgical
4.4941 of 5 stars
$463.14
+2.6%
$611.86
+32.1%
N/A$165.30B$8.35B72.4012,100News Coverage
Positive News
SYK
Stryker
4.5155 of 5 stars
$345.04
-0.2%
$421.90
+22.3%
N/A$131.73B$22.60B44.4751,000Positive News
High Trading Volume
MDT
Medtronic
4.5737 of 5 stars
$83.05
+0.2%
$96.07
+15.7%
N/A$106.51B$33.20B25.2495,000Analyst Forecast
Positive News
BDX
Becton, Dickinson and Company
4.8178 of 5 stars
$204.66
-1.3%
$275.71
+34.7%
N/A$58.81B$20.64B34.0277,000Options Volume
Analyst Revision
Positive News
EW
Edwards Lifesciences
4.5191 of 5 stars
$68.90
-0.7%
$79.95
+16.0%
N/A$40.60B$5.44B9.9117,300Analyst Forecast
News Coverage
Positive News
RMD
ResMed
4.3959 of 5 stars
$212.71
+3.7%
$249.73
+17.4%
N/A$31.21B$4.93B25.098,160Insider Trade
News Coverage
Positive News
IDXX
IDEXX Laboratories
4.1465 of 5 stars
$380.17
-3.4%
$533.75
+40.4%
N/A$30.82B$3.90B35.6510,800Analyst Downgrade
News Coverage
Positive News
High Trading Volume
DXCM
DexCom
4.8768 of 5 stars
$61.24
+2.4%
$99.82
+63.0%
N/A$24.05B$4.03B42.897,600Analyst Upgrade
News Coverage
Positive News
STE
STERIS
4.3811 of 5 stars
$212.56
0.0%
$258.75
+21.7%
N/A$20.93B$5.40B45.2416,000Analyst Forecast
News Coverage
Positive News
Remove Ads

Related Companies and Tools


This page (NYSE:BSX) was last updated on 4/13/2025 by MarketBeat.com Staff
From Our Partners